SynBioBeta Speaker

Daniel Goodman

Postdoctoral Fellow, UCSF

UCSF

YEAR

25

May 2025, SynBioBeta

Speaker

A synthetic immunologist and computational biologist working at the intersection of genome engineering, immune cell therapy, and genetic design using generative models. Working at UCSF with Kole Roybal & Alex Marson on the next generation of T cell therapies for cancer and autoimmune disease. MIT Ph. D. alum from George Church's lab.

SynBioBeta 2025 - Keynote

Designing Cellular Medicines: Using High-Throughput Experiments and AI Approaches to Program Cells to Cure Disease

We now live in a world where genetically engineered cells are circulating people's bodies and warding off cancer. But the first approved cell-based medicines—such as CAR-T therapy—are just the beginning. In this session, we'll explore the next generation of programmable cellular medicines.

SynBioBeta 2026 Tickets are Live

Confirmed Speakers

VIP Pass

9,995

USD

Conference Pass +

VIP Dinner

VIP Reception

Concierge Intros

Conference Content

Purchase Pass

Purchase Pass

Free cancelation through 2 weeks before the event, if you book before October 31st.

VIP Pass

9,995

USD

Conference Pass +

VIP Dinner

VIP Reception

Concierge Intros

Conference Content

Purchase Pass

Purchase Pass

Free cancelation through 2 weeks before the event, if you book before October 31st.

VIP Pass

9,995

USD

Conference Pass +

VIP Dinner

VIP Reception

Concierge Intros

Conference Content

Purchase Pass

Purchase Pass

Free cancelation through 2 weeks before the event, if you book before October 31st.

Previous Speakers Include

Sign Up
Sign Up